Seattle, WA · Founded 2017 · Privately Held (backing)
Operator of a clinical-stage biotechnology company intended for the development of novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system (CNS)… Proniras is based in Seattle, WA and was founded in 2017. It was valued at $17.5 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $11.2 million across 2 recorded rounds; the latest was a $6.9 million early-stage round in Dec 2023.
These 9 firms already write checks for companies like Proniras. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.